Cambridge Investment Research Advisors’s Bionano Genomics BNGO Stock Holding History

Cambridge Investment Research Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-32	Closed	-$12K	–	3150
2023 Q2	$12K	Buy	32 +3	+10%	+$1.35K	﹤0.01%	3142
2023 Q1	$19K	Buy	29 +2	+7%	+$1.78K	﹤0.01%	3104
2022 Q4	$23K	Buy	+27	New	+$34K	﹤0.01%	3032
2021 Q4	–	Sell	-28	Closed	-$91K	–	3178
2021 Q3	$91K	Sell	28 -7	-20%	-$24.5K	﹤0.01%	2969
2021 Q2	$156K	Buy	35 +2	+6%	+$7.9K	﹤0.01%	2894
2021 Q1	$158K	Buy	+33	New	+$186K	﹤0.01%	2693
2020 Q4	–	Sell	-19	Closed	-$8K	–	2716
2020 Q3	$8K	Buy	+19	New	+$7.37K	﹤0.01%	2508

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cambridge Investment Research Advisors's BNGO Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 32 shares — an estimated $12K sold.

Cambridge Investment Research Advisors first reported a position in BNGO in Q3 2020 and held it in 7 quarters. The position peaked at $158K in Q1 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

Cambridge Investment Research Advisors reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
Cambridge Investment Research Advisors sold 32 Bionano Genomics shares in Q3 2023, an estimated $12K.
Cambridge Investment Research Advisors first reported a position in Bionano Genomics in Q3 2020 and held it in 7 quarters.
Cambridge Investment Research Advisors's Bionano Genomics position peaked at $158K in Q1 2021.
46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.